The K99/R00 eligibility window for postdocs affected by the 2025 federal funding lapse closes in 2026: NIH notice NOT-OD-26-042 confirms that researchers whose 48-month eligibility ended September–November 2025 have a final submission opportunity in February/March 2026, and those whose window ended January–March 2026 have until June/July 2026. Outside these two cohorts, the standard four-year (48-month) postdoctoral eligibility limit applies unchanged.
The K99/R00 eligibility question has become urgent for a specific slice of the postdoctoral community this year, and the answer now depends on exactly when an applicant’s standard eligibility clock was due to run out. The NIH Pathway to Independence Award (K99/R00) is a two-phase career development mechanism that funds a mentored postdoctoral phase (K99) followed by an independent, tenure-track faculty phase (R00), and its eligibility rules are normally fixed and unforgiving — until a disruption like the one NIH has just addressed intervenes.
- What is the K99/R00 Pathway to Independence Award?
- What does NIH notice NOT-OD-26-042 change?
- Who qualifies under the standard eligibility rule?
- What are the exact 2026 submission deadlines?
- What should postdocs and grants offices do now?
- Answer-first Q&A
What is the K99/R00 Pathway to Independence Award?
The K99/R00 is an NIH career development award designed to help outstanding postdoctoral researchers transition from mentored training into independent, faculty-level research positions without a funding gap. The K99 phase provides up to two years of mentored salary and research support at the trainee’s current institution; the R00 phase then converts, on activation of a tenure-track offer, into up to three years of independent research funding at the hiring institution.
Under the current Parent K99/R00 funding opportunity announcements, the R00 phase carries a total-cost cap of $249,000 per year, a figure that appears consistently across participating institutes including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Eligibility is not tied to citizenship: non-U.S. citizens and permanent residents may apply, provided their visa status permits them to complete each award phase in the United States.
What does NIH notice NOT-OD-26-042 change?
NOT-OD-26-042, released by NIH on 4 March 2026, is a correction notice to NOT-OD-26-021 (released 30 January 2026), the original notice establishing a temporary K99/R00 eligibility extension. Both notices state the extension exists to “lessen the impact” of disruptions from the recent lapse in federal appropriations on application submission, peer review, and award processing.
The correction matters because it widened the covered population. NOT-OD-26-021’s original wording limited the extension to applicants whose 48-month window ended between September and November 2025. NOT-OD-26-042 removed that limiting language and confirmed a second cohort — those whose window ended January through March 2026 — is also covered, with its own later final-submission window.
This is a narrow, time-boxed policy fix, not a general loosening of K99/R00 rules. It applies automatically to new and resubmission applications under the five specified Parent K99/R00 funding opportunities and does not extend eligibility for anyone outside the two defined date ranges.
Who qualifies under the standard eligibility rule?
Outside the temporary extension, the baseline rule is unchanged: applicants must have no more than four years (48 months) of postdoctoral research experience at the time of the initial application, resubmission, or revision, counted from the date the doctoral degree requirements were completed. This threshold is confirmed independently across multiple NIH institute pages, including the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke (NINDS).
Separately from the appropriations-lapse extension, NIH also maintains a standing, always-available eligibility extension for childbirth under NOT-OD-20-011: a one-year extension applied automatically for women giving birth, with case-by-case extensions available to fathers, adoptive parents, and same-sex partners on request to the relevant institute. This childbirth extension is cumulative per applicant (a single total 12-month extension, regardless of the number of births during the eligibility window), not per event, and is entirely independent of the 2026 appropriations-related extension described above.
Key baseline requirements applicants must still satisfy:
- Hold a doctoral degree and be in a mentored, postdoctoral training position at the time of application
- Commit a minimum of 9 calendar months (75% full-time professional effort) to the award
- Not have already accepted an independent, non-mentored faculty position before the K99 is awarded
- For non-U.S. citizens, hold a visa status that permits completion of the relevant award phase in the United States
What are the exact 2026 submission deadlines?
The extension divides affected applicants into two cohorts based on when their original 48-month eligibility window was set to expire. Grants offices should check each candidate’s PhD conferral date against both rows below before assuming an applicant has already timed out.
| Original 48-month eligibility window ended | Final submission with extended eligibility | Governing notice |
|---|---|---|
| September–November 2025 | February/March 2026 due dates | NOT-OD-26-021 / NOT-OD-26-042 |
| January–March 2026 | June/July 2026 due dates | NOT-OD-26-042 |
| Outside these ranges | Standard 4-year (48-month) rule applies; no extension | Parent K99/R00 FOAs |
Applicants should note that an earlier, unrelated temporary extension tied to the COVID-19 pandemic is no longer in effect. Any eligibility calculation that assumes the pandemic-era extension still applies will be incorrect for 2026 cycles.
What should postdocs and grants offices do now?
For postdocs near the boundary of either cohort, the immediate task is arithmetic: identify the exact date the doctoral degree requirements were completed, add 48 months, and check whether that expiry date falls in one of the two windows NOT-OD-26-042 covers. If it does, the February/March or June/July 2026 due date is the last opportunity to submit a new or resubmission K99/R00 application under Parent K99/R00 eligibility rules.
Institutional grants offices and research development staff supporting multiple candidates should:
- Cross-check each mentee’s doctoral completion date against the two extension windows in the table above
- Confirm which of the five specified Parent K99/R00 funding opportunity announcements applies, since institute-specific reissues (for example, NCI’s PAR-25-135 and PAR-25-313) can carry their own instructions layered on top of the parent notice
- Flag candidates who also qualify for the separate NOT-OD-20-011 childbirth extension, since that extension can be requested independently of the 2026 appropriations-related dates
- Direct case-specific eligibility questions to the relevant NIH institute or centre, as NIH has stated inquiries should go to the IC the application will be submitted to, not a central helpdesk
Applications that miss the applicable window will not be accepted for review under K99/R00 eligibility rules regardless of scientific merit, since NIH’s Center for Scientific Review screens for eligibility compliance before any peer review occurs.
Answer-first Q&A
How do you qualify for K99/R00?
Applicants generally qualify with no more than four years (48 months) of postdoctoral research experience at application, a mentored postdoctoral position, and a commitment of at least 9 calendar months’ effort. Those whose 48-month window ended September 2025–March 2026 may still qualify under the NOT-OD-26-042 extension.
Are non-citizens eligible for the K99/R00 award?
Yes. NIH imposes no citizenship requirement for K99/R00 applicants. U.S. citizens, permanent residents, and non-U.S. citizens may all apply, provided the applicant institution documents that the candidate’s visa status allows them to complete the relevant award phase within the United States.
What visa do you need to be on for K99/R00?
There is no single mandated visa category. The applicant institution must confirm the candidate’s current visa status permits remaining in the U.S. long enough to finish the K99 phase, and the hiring institution must make the equivalent determination before the R00 phase activates.
Implications for the 2026 funding cycle
The correction from NOT-OD-26-021 to NOT-OD-26-042 illustrates how administrative disruptions at the federal level now translate directly into individual eligibility calculations for early-career researchers. A single word change — removing the phrase that limited the extension to the September–November 2025 cohort — doubled the population NIH intended to protect. Grants offices that relied on the original notice’s text without checking for a correction risked wrongly telling January–March 2026 candidates they were out of time.
Looking beyond 2026, the pattern reinforces a practical lesson for research administration: eligibility notices tied to appropriations disruptions are typically issued, then corrected, within weeks of each other. Institutions supporting K99/R00 candidates should monitor the NIH Guide for Grants and Contracts directly rather than relying solely on institute-level summaries, since those summaries can lag a correction notice by days or weeks.